ArticleTranslational gastroenterology and hepatology2017

Regorafenib: lights and shadows of antiangiogenic therapies in gastric cancer.

Caterina Vivaldi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.